BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22449963)

  • 1. Formation of amyloid fibrils from β-amylase.
    Luo JC; Wang SC; Jian WB; Chen CH; Tang JL; Lee CI
    FEBS Lett; 2012 Mar; 586(6):680-5. PubMed ID: 22449963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrational circular dichroism as a probe of fibrillogenesis: the origin of the anomalous intensity enhancement of amyloid-like fibrils.
    Measey TJ; Schweitzer-Stenner R
    J Am Chem Soc; 2011 Feb; 133(4):1066-76. PubMed ID: 21186804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
    Margittai M; Langen R
    Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt-induced modulation of the pathway of amyloid fibril formation by the mouse prion protein.
    Jain S; Udgaonkar JB
    Biochemistry; 2010 Sep; 49(35):7615-24. PubMed ID: 20712298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
    Jain S; Udgaonkar JB
    J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of randomizing the Sup35NM prion domain sequence on formation of amyloid fibrils in vitro.
    Liu Y; Wei H; Wang J; Qu J; Zhao W; Tao H
    Biochem Biophys Res Commun; 2007 Feb; 353(1):139-46. PubMed ID: 17166483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of a Ure2 C-terminal prion-inhibiting region promotes the rate of fibril seed formation and alters interaction with Hsp40.
    Chen L; Chen LJ; Wang HY; Wang YQ; Perrett S
    Protein Eng Des Sel; 2011 Jan; 24(1-2):69-78. PubMed ID: 21076138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrils of Ure2p homologs from Saccharomyces cerevisiae and Saccharoymyces paradoxus have similar cross-β structure in both dried and hydrated forms.
    Wang YQ; Bongiovanni M; Gras SL; Perrett S
    J Struct Biol; 2011 Jun; 174(3):505-11. PubMed ID: 21419850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
    Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
    J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid architecture: complementary assembly of heterogeneous combinations of three or four peptides into amyloid fibrils.
    Takahashi Y; Ueno A; Mihara H
    Chembiochem; 2002 Jul; 3(7):637-42. PubMed ID: 12324997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
    Suhre MH; Hess S; Golser AV; Scheibel T
    J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.
    Ramirez-Alvarado M; Merkel JS; Regan L
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8979-84. PubMed ID: 10908649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.